BIBLIOGRAPHIC RECORD

FDA approves new buprenorphine treatment option for opioid use disorder

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Source of metadata
Crossref
Year recorded
2023

Public identifiers and source

Open the source record

Reference

(2023). FDA approves new buprenorphine treatment option for opioid use disorder. https://doi.org/10.1002/cpu.30788

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.